BioLineRx Market Cap

BioLineRx has a market cap or net worth of 49.12 million as of May 30, 2025. Its market cap has decreased by -74.87% in one year.

Market Cap

49.12M

Enterprise Value

2.10M

Revenue

83.18M

Ranking

n/a

PE Ratio

n/a

Stock Price

2.20

Market Cap Chart

Since February 13, 2007, BioLineRx's market cap has increased from 163.03K to 49.12M, an increase of 30,028.66%. That is a compound annual growth rate of 36.60%.

Market Cap History

Date	Market Cap	% Change
May 29, 2025	49.12M	-42.58%
Dec 31, 2024	85.55M	-79.39%
Dec 31, 2023	415.08M	314.57%
Dec 29, 2022	100.12M	-67.59%
Dec 30, 2021	308.95M	60.58%
Dec 31, 2020	192.39M	108.80%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 31, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Teva Pharmaceutical Industries	73.03B
Danel (Adir Yeoshua)	2.39B
Kamada	1.39B
Bait Bakfar	1.13B
SofWave Medical	732.46M
Novolog (Pharm-Up 1966)	725.40M
BrainsWay	703.60M
Ilex Medical	683.03M

Market Cap Rankings